15451796

Source:http://linkedlifedata.com/resource/pubmed/id/15451796

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0004153, umls-concept:C0024432, umls-concept:C0026336, umls-concept:C0034493, umls-concept:C0034787, umls-concept:C0332206, umls-concept:C0332453, umls-concept:C0332461, umls-concept:C0599946, umls-concept:C0717550
pubmed:issue	14
pubmed:dateCreated	2004-10-6
pubmed:abstractText	Little is known about whether direct angiotensin receptor blockade can reduce atherosclerosis and plaque disruption. This study evaluated the effect of angiotensin receptor blockade on both the development of atherosclerosis and the disruption of plaque in a modified Constantinides animal model.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/R01 HL-61825, http://linkedlifedata.com/resource/pubmed/grant/R01 HL061825-01A1
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/15451796-10523393, http://linkedlifedata.com/resource/pubmed/commentcorrection/15451796-10639539, http://linkedlifedata.com/resource/pubmed/commentcorrection/15451796-10747338, http://linkedlifedata.com/resource/pubmed/commentcorrection/15451796-10747353, http://linkedlifedata.com/resource/pubmed/commentcorrection/15451796-11027596, http://linkedlifedata.com/resource/pubmed/commentcorrection/15451796-11423049, http://linkedlifedata.com/resource/pubmed/commentcorrection/15451796-11479463, http://linkedlifedata.com/resource/pubmed/commentcorrection/15451796-11486244, http://linkedlifedata.com/resource/pubmed/commentcorrection/15451796-11557688, http://linkedlifedata.com/resource/pubmed/commentcorrection/15451796-11723025, http://linkedlifedata.com/resource/pubmed/commentcorrection/15451796-11800413, http://linkedlifedata.com/resource/pubmed/commentcorrection/15451796-12140726, http://linkedlifedata.com/resource/pubmed/commentcorrection/15451796-12235451, http://linkedlifedata.com/resource/pubmed/commentcorrection/15451796-12426214, http://linkedlifedata.com/resource/pubmed/commentcorrection/15451796-12637340, http://linkedlifedata.com/resource/pubmed/commentcorrection/15451796-13695142, http://linkedlifedata.com/resource/pubmed/commentcorrection/15451796-15037537, http://linkedlifedata.com/resource/pubmed/commentcorrection/15451796-2649516, http://linkedlifedata.com/resource/pubmed/commentcorrection/15451796-7828306, http://linkedlifedata.com/resource/pubmed/commentcorrection/15451796-7884001, http://linkedlifedata.com/resource/pubmed/commentcorrection/15451796-8486785, http://linkedlifedata.com/resource/pubmed/commentcorrection/15451796-8653825, http://linkedlifedata.com/resource/pubmed/commentcorrection/15451796-9052782, http://linkedlifedata.com/resource/pubmed/commentcorrection/15451796-9351346, http://linkedlifedata.com/resource/pubmed/commentcorrection/15451796-9743232, http://linkedlifedata.com/resource/pubmed/commentcorrection/15451796-9797345
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0147763
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II Type 1 Receptor..., http://linkedlifedata.com/resource/pubmed/chemical/Benzimidazoles, http://linkedlifedata.com/resource/pubmed/chemical/Biphenyl Compounds, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, Dietary, http://linkedlifedata.com/resource/pubmed/chemical/Tetrazoles, http://linkedlifedata.com/resource/pubmed/chemical/candesartan cilexetil
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	1524-4539
pubmed:author	pubmed-author:Al AmmaryFawazF, pubmed-author:DolgoffJenniferJ, pubmed-author:HamiltonJamesJ, pubmed-author:HorowitzGaryG, pubmed-author:JohnstoneMichael TMT, pubmed-author:NasserImadI, pubmed-author:PerezAlexandra SAS, pubmed-author:QuistWilliam CWC, pubmed-author:SchmidtBenB, pubmed-author:StewartRobertR, pubmed-author:VaidyaAnandA
pubmed:issnType	Electronic
pubmed:day	5
pubmed:volume	110
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	2060-5
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:15451796-Angiotensin II Type 1 Receptor Blockers, pubmed-meshheading:15451796-Animals, pubmed-meshheading:15451796-Aorta, pubmed-meshheading:15451796-Aortic Diseases, pubmed-meshheading:15451796-Arteriosclerosis, pubmed-meshheading:15451796-Balloon Dilation, pubmed-meshheading:15451796-Benzimidazoles, pubmed-meshheading:15451796-Biphenyl Compounds, pubmed-meshheading:15451796-Cholesterol, pubmed-meshheading:15451796-Cholesterol, Dietary, pubmed-meshheading:15451796-Drug Evaluation, Preclinical, pubmed-meshheading:15451796-Endothelium, Vascular, pubmed-meshheading:15451796-Macrophages, pubmed-meshheading:15451796-Rabbits, pubmed-meshheading:15451796-Rupture, Spontaneous, pubmed-meshheading:15451796-Tetrazoles
pubmed:year	2004
pubmed:articleTitle	Angiotensin receptor blockade with candesartan attenuates atherosclerosis, plaque disruption, and macrophage accumulation within the plaque in a rabbit model.
pubmed:affiliation	Department of Medicine, Cardiovascular Division, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Ave, RW-453, Boston, MA 02115, USA. mjohnst1@bidmc.harvard.edu.
pubmed:publicationType	Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't